Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments

Free download. Book file PDF easily for everyone and every device. You can download and read online Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments file PDF Book only if you are registered here. And also you can download or read online all Book PDF file that related with Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments book. Happy reading Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments Bookeveryone. Download file Free Book PDF Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments at Complete PDF Library. This Book have some digital formats such us :paperbook, ebook, kindle, epub, fb2 and another formats. Here is The CompletePDF Book Library. It's free to register here to get Book file PDF Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments Pocket Guide.

Editorial Reviews

The book provides a vital resource for researchers and practitioners alike, with information relevant to gerontologists, geriatricians, sports medicine physicians, physiologists, neuroscientists, cell biologists, endocrinologists, physical therapists, allied health and musculoskeletal practitioners, strength and conditioning specialists, athletic trainers, and students of the medical and biomedical sciences. Read more Read less. Kindle Cloud Reader Read instantly in your browser. Editorial Reviews From the Back Cover Some of the most serious consequences of aging are its effects on skeletal muscle.

Product details File Size: Springer; edition November 30, Publication Date: November 30, Sold by: Share your thoughts with other customers. Write a customer review. Showing of 1 reviews. Top Reviews Most recent Top Reviews. There was a problem filtering reviews right now. Please try again later.

Kindle Edition Verified Purchase. Comprehensive information on age related sarcopenia and the best part is that they have a list of on top of the world labs in this area. Amazon Giveaway allows you to run promotional giveaways in order to create buzz, reward your audience, and attract new followers and customers. Learn more about Amazon Giveaway. Set up a giveaway. There's a problem loading this menu right now. Learn more about Amazon Prime. Get fast, free shipping with Amazon Prime. Get to Know Us. English Choose a language for shopping. Not Enabled Word Wise: The role of the UPS in non-inflammatory muscle wasting is also put into question by the observation of no change in muscle protein breakdown in the presence of insulin-mediated alterations in protein expression of atrogin-1 and MuRF1.

Even assuming that the UPS plays a role in sarcopenia, the available evidence only shows a slight elevation in basal protein breakdown in human beings. Satellite cells are quiescent myogenic precursors that play a fundamental role in muscle repair and growth. Provided the basal lamina remains intact, the myoblasts fuse with each other to form myotubes, which then mature into a new fibre or fuse with an existing one, resulting in myofibre repair. Recent investigations show that the breaking of satellite cells quiescence and the initiation of proliferation are mediated by Notch, a trans-membrane receptor.

There is a wealth of studies reporting a decline in muscle strength and power in old age for review see This problem is exacerbated in sarcopenic-obese people since not only they have a lower muscle mass available for delivering the power necessary for daily activities but they have to generate extra-power, and thus use more energy, to displace the excess body fat due their condition. Despite the fact that sarcopenia is a major determinant of muscle weakness in old age, the loss of muscle strength and power exceeds that of muscle size and volume and, as a consequence, there is a decline in force per unit of muscle cross-sectional area and in peak power per unit volume.

These factors can be grouped under two main categories: Each of these factors is discussed separately in the following sections. Among the muscular changes, a reduction in single fibre force per cross-sectional area specific tension is one of the major factors contributing to the decline in intrinsic muscle force and recent evidence suggests that this is tightly associated with a decrease in the number of actomyosin cross-bridges rather than in the force exerted by each cross-bridge. Several studies have shown an accumulation of advanced glycation end products AGEs with ageing.

These have been shown to alter the structural and functional properties of the contractile protein myosin, leading to a decrease in maximum shortening speed and specific tension 92 as well as to an increase in intramuscular collagen cross-linking 93 which is thought to be associated with an increased muscle stiffness and impaired muscle function in the elderly. The accumulation of AGEs is particularly frequent in diabetes and in individuals with low physical activity levels.

Muscle power is affected by changes in both force and velocity of shortening. In addition to the above-listed causes of the loss in muscle force together with changes in neural drive in the case of voluntary contractions, see below , factors contributing to the loss in shortening velocity in old age are a selective loss of fast twitch fibres whose power is about 10 times higher than that of slow fibres 94 and a decrease in the intrinsic speed of shortening of the myosin molecule.

Other contributors include a reduction in neural drive to the agonist muscles and an increase in neural drive to the antagonist muscles. Several investigators have found a reduced activation capacity in older individuals, 10 , 95 , 96 while others reported no differences, 97—99 although it is generally agreed that a considerable heterogeneity in activation capacity exists among muscles.

Ageing not only involves qualitative and quantitative changes of skeletal muscles but also of tendons. Tendon mechanical properties studied in vivo with ultrasonography have been found to be significantly deteriorated in old age. These alterations in tendon properties with old age are expected to have a direct impact on muscle mechanical behaviour by affecting the degree of shortening of muscle fibres and the rate of force development upon contraction.

This greater shortening upon contraction may place fascicles in a non-favourable portion of the length—tension relationship and may thus contribute to the loss of intrinsic muscle force with ageing. Sarcopenia has a complex aetiology involving neuronal, hormonal, immunological, nutritional and physical activity mechanisms. Although this process affects both genders, women are more at risk of losing functional independence than men are since they live longer and at any given age have a lower muscle mass than men also because they display greater blunting of the anabolic response to exercise and feeding in addition to blunting of the antiproteolytic effect of insulin.

However, muscle mass in old age is not only lost due to reduced anabolism and increased catabolism, but also due to a reduced capacity of muscle regeneration as satellite cell activation and proliferation becomes impaired in old age. Lastly, the increased prevalence of obesity in the older population is a recognized compounding factor of sarcopenia, giving rise to SO, a condition that likely contributes to the loss of muscle mass, mobility and independence in old age.

Although considerable knowledge has been gained on the prevalence, aetiology and functional consequences of sarcopenia, much remains to be elucidated. For instance, efforts should be made to dissociate the effects of ageing per se from those of disuse and disease. Most of the available knowledge in this field is based on cross-sectional studies comparing young and older people with diverse genetic and phenotypic characteristics, thus unconsciously assuming that the same determinants drive the ageing process of different individuals.

More longitudinal studies are needed, playing specific attention to the choice of a representative phenotype, or a minimal battery of phenotypes affecting different characteristics strength, fatigability, power, balance, coordination. Future workers should also attempt to clarify the role of muscle protein breakdown in medically stable older people, as many current views of the immediate causes of atrophy place what may be unwarranted emphasis on its role.

In fact there is no published evidence deriving from modern methods of measurement of muscle protein breakdown in older people showing that it is elevated; furthermore none of the so-called proteolytic markers have not been validated against such methods. Also, evidence of activation of the ATP dependent ubiquitin-proteasome pathway and of the other pathways involving caspase and autophagy comes mainly from increased expression of mRNA not protein or even measured enzyme activity and derives from studies of rodents with a distinctly different lifetime pattern of protein turnover than is seen in people.

In human beings, evidence of activation of the UPS comes from studies performed on cachectic patients, who may show both a faster and different mode of wasting characterized by activation of catabolic hormones and inflammation. Although strong evidence exists that regular resistive exercise slows down the ageing-associated decrease in muscle mass, its possible role in protecting against the loss of motor units should be further explored. Other possible treatments deserving attention include selective androgen receptor molecules and anti-myostatin antibodies, both of which are currently in phase II trials in the USA.

Whether muscle regenerative capacity through activation of notch-mediated satellite cells proliferation can be modulated by targeted pharmacological interventions seems an approach also worth investigating.

Find a copy online

Finally, more understanding on the exact causes of the blunted anabolic response of older women to feeding and resistive exercise needs to be gained. Original work in Prof. Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide.

Sign In or Create an Account. Close mobile search navigation Article navigation. Regional distribution of sarcopenia. Intramuscular fat accumulation and SO. Muscle fibre size, number and composition. Satellite cells and myonuclear number. Changes in muscle architecture. Capacity for muscle regeneration. Functional consequences of sarcopenia. Abstract Sarcopenia reflects a progressive withdrawal of anabolism and an increased catabolism, along with a reduced muscle regeneration capacity. View large Download slide. Low relative skeletal muscle mass sarcopenia in older persons is associated with functional impairment and physical disability.

Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients. Reduced plantarflexor specific torque in the elderly is associated with a lower activation capacity. Decline in isokinetic force with age: Knee extensor strength, activation, and size in very elderly people following strength training.

Alterations in muscle attenuation following detraining and retraining in resistance-trained older adults. Skeletal muscle contractile and noncontractile components in young and older women and men. Knee extension strength and walking speed in relation to quadriceps muscle composition and training in elderly women.

Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22—65 years.

Distribution of different fiber types in human skeletal muscles: Ageing alters the myosin heavy chain composition of single fibres from human skeletal muscle. Morphological and functional characteristics of the ageing skeletal muscle in man. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from to year-old men.

Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women. Function, morphology and protein expression of ageing skeletal muscle: Co-existence of myosin heavy chain I and IIa isoforms in human skeletal muscle fibres with endurance training. The effect of ageing and immobilization on structure and function of human skeletal muscle fibres.

Product details

Deterioration of contractile properties of muscle fibres in elderly subjects is modulated by the level of physical activity. Molecular basis of skeletal muscle plasticity—from gene to form and function. Different effects on human skeletal myosin heavy chain isoform expression: Contractile properties of skeletal muscles from young, adult and aged mice. Distribution of different fibre types in human skeletal muscles. Fibre type arrangement in m. No decrease in myonuclear number after long-term denervation in mature mice. Evidence that satellite cell decrement contributes to preferential decline in nuclear number from large fibres during murine age-related muscle atrophy.

Influence of muscle architecture on the torque and power-velocity characteristics of young and elderly men. Muscle-fiber pennation angles are greater in hypertrophied than in normal muscles. Time course of muscular neural tendinous adaptations to 23 day unilateral lower-limb suspension in young men.

The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse.

A method for estimating the number of motor units in thenar muscles and the changes in motor unit count with ageing. Age-associated changes in the innervation of muscle fibers and changes in the mechanical properties of motor units. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration. Effects of aging and caloric restriction on mitochondrial energy production in gastrocnemius muscle and heart.

Update on emerging drugs for sarcopenia - age-related muscle wasting.

Premature ageing in mice expressing defective mitochondrial DNA polymerase. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Aging, muscle fiber type, and contractile function in sprint-trained athletes. Effects of aging on actin sliding speed on myosin from single skeletal muscle cells of mice, rats, and humans. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass sarcopenia: Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol.

Myofibrillar protein synthesis in young and old human subjects after three months of resistance training.

Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Basal muscle amino acid kinetics and protein synthesis in healthy young and older men. The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle.

Molecular mechanisms in aging and current strategies to counteract sarcopenia.

Anabolic signaling and protein synthesis in human skeletal muscle after dynamic shortening or lengthening exercise. Blunting of insulin inhibition of proteolysis in legs of older subjects may contribute to age-related sarcopenia. A leucine-supplemented diet restores the defective postprandial inhibition of proteasome-dependent proteolysis in aged rat skeletal muscle.

Facts, noise and wishful thinking: The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. Muscle strength, power and adaptations to resistance training in older people. Strength, power and related functional ability of healthy people aged 65—89 years.

Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments
Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments
Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments
Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments
Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments

Related Sarcopenia – Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments

Copyright 2019 - All Right Reserved